Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: Evidence for undertreatment in women and the elderly

Archives of Internal Medicine

Volumn 156, Issue 7, 1996, Pages 799-805

  McLaughlin, Thomas J ^a   Soumerai, Stephen B ^a   Willison, Donald J ^b   Gurwitz, Jerry H ^c   Borbas, Catherine ^d   Guadagnoli, Edward ^a   McLaughlin, Barbara ^d   Morris, Nora ^d   Cheng, Su Chun ^b   Hauptman, Paul J ^a   Antman, Elliott ^a   Casey, Linda ^a   Asinger, Richard ^e   Gobel, Fredarick ^f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Hlthcare Educ and Res Foundation   (United States)

^e HENNEPIN COUNTY MEDICAL CENTER   (United States)

^f Minnesota Heart Institute Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; LIDOCAINE;

ACUTE HEART INFARCTION; ARTICLE; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; DRUG USE; ELDERLY CARE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; ANTI-ARRHYTHMIA AGENTS; ASPIRIN; DRUG UTILIZATION; FEMALE; HUMANS; LIDOCAINE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES; SEX FACTORS; THROMBOLYTIC THERAPY;

EID: 13344261964     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.7.799     Document Type: Article

References (22)

1. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates: an analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984;101:825-836.
2. Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials Prog Cardiovasc Dis. 1985, 17:335-371
3. Yusuf S, Sleight P, Held P, McMahon S. Routine medical management of acute myocardial infarction lessons from overviews of recent randomized controlled trials Circulation 1990;82(suppl 2).117-134.
4. ISIS-1 (First International Study of Infarct Survival). Collaborative Group: randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986;2:57-65.
5. ISIS-2 (Second International Study of Infarct Survival). Collaborative Group: randomised trial of intravenous streptokmase. oral aspirin, both or neither among 17,187 cases of suspectad acute myocardial infarction: ISIS-II. Lancet. 1988; 2:349-360.
6. Gurwrtz JH, Goldberg RJ, Gore JM Coronary thrambolysis for the elderly. JAMA 1991,265:1720-1723.
7. Jansen RWMM, Gurwitz JH. Controversies surrounding the use of beta-blockers in older patients with cardiovascular disease. Drugs Aging 1994;4 175-183.
8. Hine LK, Laird N. Hewrtt P, Chalmers T. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med. 1989; 149 2694-2698
9. ACC/AHA Task Force. Guidelines for the early management of patients with acute myocardial infarction: a report of trie American College of Cardiology/ American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients With Acute Myocardial Infarction) J Am Coll Cardiol. 1990;16:249-292.
10. Soumerai SB, McLaughlin TJ, Avorn JA Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q 1989; 67:268-317.
11. Pashos GL, Normand SLT, Garfinkle JB, et al. Trends in the use of drug therapies in patients with acute myocardial infarction. 1988 to 1992 J Am Coll Cardiol. 1994;23:1023-1030.
12. Ayanian J, Hauptman PJ, Guadagnoli E, et al. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med. 1994,331:1135-1142.
13. Udvarhelyi IS, Gatsonis C, Epstein AM, Pashos CL, Newhouse JP, MeNeil BJ. Acute myocardial infarction in the Medicare population: process of care and clinical outcomes JAMA. 1992;268:2530-2536.
14. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation. 1994,90.2103-2114.
15. Meehan TP, Hennen J, Radford MJ. et al. Process and outcome of care for acute myocardial infarction among Medicare beneficiaries in Connecticut: a quality improvement demonstration project. Ann Intern Med. 1995.122:928-936.
16. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction: tour-state pilot study from the Cooperative Cardiovascular Proiect JAMA 1995;273:1509-1514.
17. Borbas C, McLaughlin D, Schultz A Minnesota Clinical Comparison and Assessment Program: bridging the gap between clinical guidelines and clinical practice. In: Coors B, ed. Bridging the Gap Between Theory and Practice Guidelines. St Paul, Minn: Hospital Research and Educational Trust; 1993.37-77.
18. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
19. National Heart, Lung, and Blood Institute. Morbidity and Mortality: Chartbook on Cardiovascular, Lung, and Blood Diseases. Bethesda, Md US Dept of Health and Human Services, Public Health Service, National Institutes of Health; January 1992
20. National Heart, Lung, and Blood Institute. Emergency Department: Rapid Identification and Treatment of Patients With Acute Myocardial Infarction. Bethesda, Md: US Dept of Health and Human Services, Public Health Service, National Institutes of Health; September 1993
21. Fibrinolytic Therapy Trialists' Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994;343:311-322.
22. Gurwitz JH, Col MF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992;268 1460-1467.